Showing results (481-490 of 500) with videos related to

Sort By:
Pageof 50
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Molecular Genetics and Metabolism|November 25, 2015
Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance inductionPriya S Kishnani, Patricia I Dickson, Laurie Muldowney, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer TherapyHoward R Seay, Amy L Putnam, Judit Cserny, et al.
JCI Insight|July 29, 2021
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetesShen Dong, Kamir J Hiam-Galvez, Cody T Mowery, et al.
Nature Immunology|September 29, 2020
Functional CRISPR dissection of gene networks controlling human regulatory T cell identityKathrin Schumann, Siddharth S Raju, Michael Lauber, et al.
The New England Journal of Medicine|June 11, 2019
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesKevan C Herold, Brian N Bundy, S Alice Long, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic miceDaniel B Rainbow, Carolyn Moule, Heather I Fraser, et al.
Nature|June 6, 2020
CRISPR screen in regulatory T cells reveals modulators of Foxp3Jessica T Cortez, Elena Montauti, Eric Shifrut, et al.
Cell Reports|October 19, 2022
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protectionDerek VanDyke, Marcos Iglesias, Jakub Tomala, et al.
Pageof 50